Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.73%
EBIT Growth (5y)
20.15%
EBIT to Interest (avg)
27.35
Debt to EBITDA (avg)
1.33
Net Debt to Equity (avg)
0.26
Sales to Capital Employed (avg)
0.79
Tax Ratio
16.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.70%
ROCE (avg)
20.58%
ROE (avg)
15.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
48
Industry P/E
34
Price to Book Value
5.98
EV to EBIT
37.29
EV to EBITDA
28.15
EV to Capital Employed
4.95
EV to Sales
7.13
PEG Ratio
32.34
Dividend Yield
0.04%
ROCE (Latest)
13.26%
ROE (Latest)
12.39%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 6.56 times
OPERATING PROFIT TO NET SALES(Q)
Highest at 27.01%
PBT LESS OI(Q)
Highest at Rs 568.04 cr.
PBDIT(Q)
Highest at Rs 929.88 cr.
PAT(Q)
Highest at Rs 574.01 cr.
EPS(Q)
Highest at Rs 13.43
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 482.77 cr
Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Operating Profit to Interest - Quarterly
Highest at 6.56 times and Grown
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Profit Margin - Quarterly
Highest at 27.01% and Grown
each quarter in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 568.04 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 929.88 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 568.04 cr has Grown at 25.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 451.01 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 574.01 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 574.01 cr has Grown at 22.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 467.41 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 13.43
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Mankind Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 482.77 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
